Transient Asystole after Sugammadex Administration for Immediate Reversal of Deep Blockade while on Dexmedetomidine Infusion in a Super Obese Patient

Sugammadex is increasingly used to reverse aminosteroid neuromuscular blocking agents. Dosing is calculated based on actual body weight, even for those who are obese. We report a case where a super obese patient (BMI 58.5 kg/m(2)) developed asystole, following coadministration with dexmedetomidine,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gajewski, Michal, Esochaghi, Sorochi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556339/
https://www.ncbi.nlm.nih.gov/pubmed/31263603
http://dx.doi.org/10.1155/2019/2709568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556339/
https://www.ncbi.nlm.nih.gov/pubmed/31263603
http://dx.doi.org/10.1155/2019/2709568

Ejemplares similares